The second time is not the charm…
The second time is not the charm for Replimune’s melanoma [...]
The second time is not the charm for Replimune’s melanoma [...]
As geopolitics bring reshoring interest to a fever pitch, the [...]
Novartis is making further workforce reductions at its U.S. headquarters [...]
Charles River Laboratories has backed an American Heart Association campaign, [...]
Envision Pharma Group has hired clinical research veteran Nick Jones [...]
The wait is over. Fierce Biotech has unveiled its ranking [...]
La finasterida, un fármaco para frenar la caída del cabello, [...]
Portuguese biopharma Bial is launching a year-long disease awareness campaign [...]
Novartis is launching a three-front push to close healthcare gaps [...]
Too much information, uncertainty and financial worries are hitting Americans [...]